计算机行业事件点评 金融科技迎来新一轮政策与创新共振机遇 2025 年 10 月 08 日 ➢ 事件： 9 月 29 日，国家发改委举行例行新闻发布会，国家发改委政策研究 室副主任、新闻发言人李超表示，当前经济运行当中依然面临着不少的风险和挑 战，国家发改委将持续发力，适时加力实施宏观政策。 ➢ 金融政策发力支持，支持宏观经济运行。针对设立新型政策性金融工具的进 展情况，李超介绍，为贯彻落实党中央、国务院决策部署，促进金融更好服务实 体经济，推动扩大有效投资，国家发改委会同有关方面积极推进新型政策性金融 工具有关工作。新型政策性金融工具规模共 5000 亿元，全部用于补充项目资本 金。金融政策持续发力，资本市场有望迎来基本面与流动性改善的共振，直接利 好政策敏感度较高的金融科技板块。 ➢ 上海成立数币运营中心，金融创新再迎新举措。9 月 24 日，数字人民币国 际运营中心在上海正式运营。数字人民币国际运营中心由中国人民银行数字货币 研究所筹建和管理，负责建设运营数字人民币跨境和区块链基础设施，本次同步 推出 3 大数字人民币运营平台：1）跨境数字支付平台，立足于支持人民币国际 化与跨境使用，为央行数字货币跨境 ...

Group 1 - Institutional research is actively seeking quality investment opportunities ahead of the National Day holiday, with around 200 listed companies receiving investor inquiries from September 22 to September 28, particularly in the technology and high-end manufacturing sectors [1] - Companies' fourth-quarter operational plans, order status, production capacity, and overseas expansion are key focus areas for institutional investors, indicating a positive outlook for several industries [1][4] Group 2 - The electronic, AI, and electrical equipment sectors are receiving significant attention from institutional investors, with companies like Jingzhida being the most favored, hosting nearly 150 institutional inquiries during the specified period [2] - Jingzhida is focusing on its computing chip testing business, emphasizing the integration of computing and storage chips in the AI era, and plans to collaborate closely with downstream clients to provide high-end testing solutions [2] Group 3 - Ant Group and Gaweida have established a strategic partnership aimed at leveraging AI big data services in the banking and fintech sectors, with a projected global fintech market size exceeding $450 billion by 2025 [3] - Companies like Xintai are exploring AI applications in biopharmaceuticals, while Jinggong Technology is advancing its exoskeleton robot development, aiming for mass production of its second-generation model [3] Group 4 - Many companies report a strong order backlog and saturated production capacity, reflecting robust business momentum and industry vitality [4][5] - For instance, ShenNan Circuit is expanding its PCB production capacity through new factories and technological upgrades, while Huatuo Cable is facing capacity constraints despite having ample orders [4][5] Group 5 - Companies like Dangsheng Technology are achieving significant breakthroughs in both production capacity and sales, with plans to increase lithium iron phosphate production capacity to 120,000 tons annually by the second half of 2025 [5] - Mingtai Aluminum is also expanding its overseas production capacity, with plans to invest in a new cold-rolled project to increase capacity by 30,000 to 40,000 tons [5] Group 6 - Huidian Co.'s production base in Thailand is set to enter small-scale production by the second quarter of 2025, with expectations of gradually releasing production capacity and achieving economic scale by the end of 2025 [6]

Investment Rating - The report initiates coverage with an "Outperform" rating and sets a target price of RMB 30.69 for 2026, based on the company's growth potential in AI and financial big data services [1][5][33]. Core Insights - The company, established in 1998, is a veteran bank IT service provider with over 20 years of experience, focusing on providing comprehensive IT solutions to financial institutions, including banks, insurance, and securities [17][34]. - The company is advancing its partnership with Ant Group to explore AI applications in banking, particularly in credit scenarios, aiming to create a closed-loop capability of "technology-scenario-implementation" [5][35][21]. - The establishment of an AI and financial big data division aims to build a leading financial AI Agent service platform, focusing on innovative revenue-sharing business models [5][24][35]. - The company has made a strategic investment in Digital Asset Clearing Services Co., Ltd. (DACS), positioning itself as a bridge for integrating traditional finance with Web3.0 and digital RMB [5][25][36]. Financial Summary - The company forecasts total revenue for 2025-2027 to be RMB 15.42 billion, RMB 20.12 billion, and RMB 25.45 billion, with year-on-year growth rates of 31%, 30%, and 26% respectively [3][12]. - Net profit attributable to the parent company is projected to be RMB 0.44 billion, RMB 1.10 billion, and RMB 2.32 billion for the same period, reflecting significant growth rates of 42%, 149%, and 110% [3][12]. - The report anticipates EPS of RMB 0.10, RMB 0.25, and RMB 0.52 for 2025, 2026, and 2027 respectively [3][12]. Business Segmentation - The company segments its business into software, system integration, and innovative services, with expected revenue growth rates of 10%, 8%, and 5% for software services from 2025 to 2027 [9][11]. - The system integration business is expected to maintain a smaller scale, with a projected growth rate of 40% in 2025, followed by stagnation [9][11]. - The innovative business, focusing on AI applications, is expected to see substantial growth, with revenues projected at RMB 2.10 billion, RMB 5.88 billion, and RMB 10.58 billion for 2025-2027 [9][11]. Market Trends - The financial technology investment in China has been increasing, with a notable rise from RMB 225.26 billion in 2019 to RMB 355.81 billion in 2023, indicating a compound annual growth rate of 14.48% [19][20]. - The bank IT solutions market is also expanding, with a CAGR of 11% for bank IT investments and 8% for the bank IT solutions market from 2019 to 2023 [19][20].

Core Viewpoint - The report highlights significant target price increases for several listed companies from September 22 to September 28, indicating potential investment opportunities in the software development, plastics, and passenger vehicle sectors [1][2]. Group 1: Target Price Increases - The companies with the highest target price increases include: - Gaweida (高伟达) with a target price increase of 123.43% [2] - Dongcai Technology (东材科技) with a target price increase of 59.60% [2] - SAIC Motor (上汽集团) with a target price increase of 54.05% [2] - Other notable companies with significant target price increases include: - Hengrui Medicine (恒瑞医药) at 47.27% [2] - Shenling Environment (申菱环境) at 46.59% [2] - Yifeng Pharmacy (益丰药房) at 45.04% [2] Group 2: Broker Recommendations - A total of 366 listed companies received broker recommendations during the same period, with notable mentions: - Tianshili (天士力) received recommendations from 6 brokers [3] - Wanwei High-tech (皖维高新) received recommendations from 3 brokers [3] - Yinlun Shares (银轮股份) also received recommendations from 3 brokers [3] Group 3: Rating Adjustments - There were 14 instances of rating upgrades, including: - Yunding Technology (云鼎科技) upgraded from "Hold" to "Buy" by Dongbei Securities [6] - Landai Technology (蓝黛科技) upgraded from "Hold" to "Buy" by Caitong Securities [6] - Jiasheng Group (健盛集团) upgraded from "Hold" to "Buy" by CITIC Securities [6] - Conversely, 6 instances of rating downgrades were noted, including: - Binglun Environment (冰轮环境) downgraded from "Strong Buy" to "Buy" by Founder Securities [7] - Kuncai Technology (坤彩科技) downgraded from "Buy" to "Hold" by CITIC Securities [7] Group 4: First Coverage - During the same period, 115 instances of first coverage were reported, with companies such as: - Tongling Nonferrous Metals (铜陵有色) receiving a "Buy" rating from Western Securities [8] - Lifan Pharmaceutical (立方制药) also receiving a "Buy" rating from Western Securities [8] - Xinjiang Zhonghe (新疆众和) receiving an "Increase" rating from Shenwan Hongyuan Group [8]

Group 1 - In the past five trading days, a total of 196 companies were investigated by institutions, with a significant focus on companies like Jingzhida, Xinlitai, and Enhua Pharmaceutical [1] - Among the companies investigated, 29 received attention from more than 20 institutions, with Jingzhida being the most popular, attracting 138 institutions [1] - The types of institutions involved in the investigations included 171 securities companies, 118 fund companies, and 57 private equity firms, indicating a strong interest from the securities sector [1] Group 2 - In terms of capital inflow, 8 out of the 29 companies that attracted more than 20 institutions saw net capital inflows, with Dangsheng Technology receiving the highest net inflow of 293 million yuan [1] - The performance of the investigated stocks showed that 12 companies experienced price increases, with Shen Gong Co., Jingzhida, and Xinlitai leading with gains of 31.80%, 17.68%, and 15.81% respectively [2] - Conversely, 17 companies saw declines, with Han Zhong Precision, Kexing Pharmaceutical, and Gao Weida experiencing the largest drops of 13.31%, 9.84%, and 9.25% respectively [2] Group 3 - The most frequently investigated company was Binglun Environment, which was surveyed 4 times, while Hu Dian Co. and Fule New Materials were investigated 3 and 2 times respectively [1] - The detailed list of companies investigated includes various sectors such as machinery, pharmaceuticals, and electronics, highlighting a diverse interest from institutions [2][3]

Group 1 - The core viewpoint of the article highlights significant target price increases for certain companies, with notable mentions being Gao Weida, Dongcai Technology, and SAIC Motor, which saw target price increases of 123.43%, 59.60%, and 54.05% respectively [1] - The article reports that from September 22 to September 28, a total of 116 target price adjustments were made by brokerages for listed companies, indicating active market analysis and adjustments [1] - In terms of downgrades, six companies had their ratings lowered during the same period, including a downgrade of Ice Wheel Environment by Founder Securities from "Strong Buy" to "Buy" [1] Group 2 - The industries represented by the companies with increased target prices include software development, plastics, and passenger vehicles, indicating diverse sectors experiencing positive market sentiment [1] - Other notable downgrades include Citic Securities lowering the rating of Kuncai Technology from "Buy" to "Hold" and Zhongtai Securities downgrading Jingwei Hengrun from "Buy" to "Hold" [1] - The overall trend suggests a mixed sentiment in the market, with some companies experiencing significant upward adjustments while others face downgrades [1]

Core Viewpoint - The article highlights the positive outlook for Gaweida, a leading financial information solution provider in China, with a "buy" rating due to its strong client base and growth potential in the AI-driven financial sector [1] Company Overview - Gaweida has established a solid customer base primarily in the banking sector, extending its services to insurance and securities [1] - The company is actively collaborating with Ant Group to explore financial AI applications, particularly in bank credit scenarios, aiming to create a second growth curve and enhance overall gross margin [1] Financial Projections - The company is expected to experience significant net profit growth due to its low marginal costs and pronounced profit effects as a software company [1] - Projected price-to-earnings (PE) ratios for 2025, 2026, and 2027 are estimated at 215, 32, and 23 times, respectively [1] - A target price of 51.5 yuan for 2026 is established based on price-to-sales (PS) valuation method, supporting the "buy" rating [1]

Core Viewpoint - The article highlights the recent performance of various listed companies based on institutional research activities, emphasizing the positive stock price movements of companies like 精智达 and 信立泰, driven by strategic developments and market demand [3][5]. Group 1: Institutional Research and Stock Performance - A total of 234 listed companies disclosed institutional research minutes this week, with nearly 40% of these companies experiencing positive stock returns [3]. - 精智达 (688627) saw a stock price increase of 17.68% after being researched by 138 institutions, focusing on its core business in display panels and semiconductor testing equipment [3]. - Other companies like 海博思创, 新坐标, and 沃尔德 also reported significant stock price increases of 32.19%, 25.03%, and 20.81% respectively during the week [3]. Group 2: Company Developments and Strategic Focus - 精智达's management indicated that the company has successfully completed its annual targets for FT testing machines and is making steady progress in KGSDCP testing machines, with strong demand in the aging testing machine sector [4]. - The company is building a complete product line around AI demands, focusing on storage, computing power, and human-machine interaction, positioning itself as a foundational player in semiconductor testing equipment for the AI era [5]. - 信立泰 hosted a roadshow and received inquiries about the impact of geopolitical factors on its US subsidiary and the role of AI in shortening R&D cycles, indicating a proactive approach to addressing investor concerns [7]. Group 3: Mergers and Collaborations - 盟科药业 announced a significant change in its controlling shareholder and plans to raise up to 10.33 billion yuan through a private placement, which will enhance its operational capabilities [10]. - 高伟达's strategic partnership with 蚂蚁数科 aims to leverage AI and big data in financial technology, highlighting the importance of collaboration in enhancing service capabilities and market reach [12].

Summary of Key Points Core Viewpoint - This week, 234 listed companies disclosed institutional research records, with nearly 40% of the companies experiencing positive stock performance, indicating a strong interest from institutional investors in various sectors [1][2]. Group 1: Institutional Research and Stock Performance - 32.19% increase in stock price for Haibo Sichuang during the week [1] - 25.03% increase in stock price for Xin Zuo Biao, marking its first board appearance [1] - 20.81% increase in stock price for World [1] Group 2: Notable Companies and Their Developments - Jingzhida (688627) received attention from 138 institutions, with a stock price increase of 17.68%. The company focuses on display panels and semiconductor testing equipment, highlighting advancements in storage testing and AI-related product lines [2] - Xintai's stock rose 15.81% after hosting a roadshow with 77 institutional investors. The company specializes in pharmaceuticals and medical devices, with over 80% of revenue from its formulation business [2] - Mengke Pharmaceutical hosted 66 institutions and announced a change in its controlling shareholder, planning to raise up to 1.033 billion yuan through a private placement [2] Group 3: Strategic Partnerships and Collaborations - Gaowei Da attracted 40 institutional investors due to a strategic partnership with Ant Group, focusing on AI and big data in financial technology [2] - The partnership aims to leverage both companies' strengths to enhance service capabilities and technology solutions in the financial sector [2]

Group 1 - A total of 234 listed companies disclosed institutional research records this week, with nearly 40% of them achieving positive stock returns [1] - The stock price of Jingzhida (688627) increased by 17.68% after receiving 138 institutional inquiries, focusing on its storage testing and semiconductor testing equipment [1][2] - Xintai's stock rose by 15.81% after hosting a roadshow with 77 institutional investors, with its core revenue source being over 80% from its formulation business [2] Group 2 - Mengke Pharmaceutical announced a stock issuance plan at a price of 6.3 yuan per share, raising up to 1.033 billion yuan, with Haiqing Pharmaceutical becoming the controlling shareholder [3] - Haiqing Pharmaceutical will leverage its experience in raw material drug development to enhance Mengke's product cost efficiency and profitability [3] - Gaowei Technology received attention from over 40 institutions due to its strategic partnership with Ant Group, focusing on AI and financial technology [4][5]